These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 938021

  • 1. Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.
    Jones RN, Fuchs PC.
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1066-9. PubMed ID: 938021
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL, Schoenknect FD, Shadomy S, Sherris JC, Thornsberry C, Washington JA, Kammer RB.
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [Abstract] [Full Text] [Related]

  • 4. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL, Jones RN, Thornsberry C.
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [Abstract] [Full Text] [Related]

  • 5. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC, Ehret JM.
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Microbiological activity of cefazedone as compared to cefazolin and cephalothin.
    Knothe H.
    Arzneimittelforschung; 1979 Jun; 29(2a):378-81. PubMed ID: 39575
    [Abstract] [Full Text] [Related]

  • 9. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
    Braveny I, Dickert H, Machka K.
    Infection; 1979 Jun; 7(5):231-6. PubMed ID: 389804
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV, Sanders CC, Sanders W.
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
    Yeh LL, Chi CL.
    Int J Antimicrob Agents; 2001 Jun; 17(6):521-4. PubMed ID: 11397625
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
    Greenberg RN, Bollinger M.
    Clin Ther; 1985 Jun; 7(2):151-3. PubMed ID: 3886140
    [Abstract] [Full Text] [Related]

  • 18. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.
    Eykyn S, Jenkins C, King A, Phillips I.
    Antimicrob Agents Chemother; 1976 Apr; 9(4):690-5. PubMed ID: 1267441
    [Abstract] [Full Text] [Related]

  • 19. Disk susceptibility studies with cefazolin and cephalothin.
    Actor P, Guarini J, Uri J, Dickson J, Pauls JF, Weisbach JA.
    Antimicrob Agents Chemother; 1974 Jan; 5(1):63-7. PubMed ID: 4840450
    [Abstract] [Full Text] [Related]

  • 20. Relationships between in vitro susceptibility and efficacy in experimental mouse infection-protection assay of cefazolin and cephalothin using Escherichia coli strains.
    Uri JV, Actor P, Phillips L, Guarini JR, Weisbach JA.
    Chemotherapy; 1976 Jan; 22(5):313-8. PubMed ID: 780071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.